Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02620085
Other study ID # 201107013RC
Secondary ID
Status Recruiting
Phase N/A
First received November 4, 2015
Last updated December 1, 2015
Start date July 2011
Est. completion date July 2021

Study information

Verified date November 2015
Source National Taiwan University Hospital
Contact Shyang-Rong Shih, Doctor
Phone 886-972653337
Email srshih@ntu.edu.tw
Is FDA regulated No
Health authority Taiwan: Ministry of Health and Welfare
Study type Observational

Clinical Trial Summary

Observe the relationship between thyroid function and personality traits


Description:

Thyrotoxicosis was the biochemical and physiological manifestations of excess thyroid hormone. The clinical manifestation was palpitation, heat intolerance, hand tremor, and weight loss. The clinical manifestation also included nervous system, including anxiety, tension, irritability, hyperactivity, fatigue, and insomnia.

Where tensions features include restless, short attention span, and the impulse to want to move around. Some patients will progress to a non-specific psychiatric disorders. According to the study, about 10% of patients will occur very frank psychosis, 3, 31% to 69% of patients with depressive symptoms, 61% to 62% of patients with symptoms of anxiety.

Some studies using reliable evaluation tool to evaluate behavioral changes in patients with thyrotoxicosis, such as Clyde emotional scale, multi-faceted personality assessment table (Multiphasic Personality Inventory (MMPI)), or observation of a response time to visual or audio stimulation. After treatment of thyrotoxicosis, most of these indicators have improved, but some indicators were still abnormal after treatment of thyrotoxicosis, such as MMPI and voice response time.

The physiological causes of the changes of these nervous system is not clear. The symptoms was improved after the use of sympathetic inhibitors, so presumably this may correlated with autonomic nervous system disorders.

Thyroid hormone receptors are widely distributed in the brain may also be one of the cause. But there still some other reasons for the changes of neurological symptoms because neurological symptoms may not be back to normal even after thyroid function returned to normal. Autoimmune dysfunction affect brain function may be the most possible reason. Graves' disease is the most common cause of thyrotoxicosis and it is related to autoimmune thyroid antibodies.

Clinically, some patients of Graves' disease may combined with other autoimmune disease, such as Sicca syndrome. The patient may still have nervous personality traits despite normalized thyroid function. Some patients even need long-term use of anti-anxiety medication.

In this study, investigators hope to analyze the personality traits of patients with hyperthyroidism,especially patients of Graves' disease, in Taiwan and to observe the changes during treatment. Investigators also hope to observe the statistical change of other non-thyroid-specific autoimmune index in this thyrotoxicosis patient. After obtaining these results, investigators will evaluate whether to continue to study the hypothesis of affection of brain of thyrotoxic patients by the abnormal autoimmune system.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date July 2021
Est. primary completion date July 2021
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 85 Years
Eligibility Inclusion Criteria:

- aged between 20 and 85 years

- euthyroid Graves' disease

Exclusion Criteria:

- Patients who were not capable to complete the questionnaire due to severe cognitive dysfunction or under education were excluded from this study

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
blood sampling
blood sampling

Locations

Country Name City State
Taiwan Shyang-Rong Shih Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

References & Publications (18)

BARTHOLOMEW AA, MARLEY E. The temporal reliability of the Maudsley personality inventory. J Ment Sci. 1959 Jan;105(438):238-40. — View Citation

Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb;123(2):183.e1-9. doi: 10.1016/j.amjmed.2009.06.030. — View Citation

BURSTEN B. Psychoses associated with thyrotoxicosis. Arch Gen Psychiatry. 1961 Mar;4:267-73. — View Citation

Chen CA, Liao SC, Wang JK, Chang CI, Chiu IS, Chen YS, Lu CW, Lin MT, Chiu HH, Chiu SN, Hua YC, Lue HC, Wu MH. Quality of life in adults with congenital heart disease: biopsychosocial determinants and sex-related differences. Heart. 2011 Jan;97(1):38-43. doi: 10.1136/hrt.2010.200709. Epub 2010 Oct 26. — View Citation

Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bull. 1973 Jan;9(1):13-28. — View Citation

EYSENCK HJ. Personality. Annu Rev Psychol. 1952;3:151-74. — View Citation

Hsu YC, Liou JM, Liao SC, Yang TH, Wu HT, Hsu WL, Lin HJ, Wang HP, Wu MS. Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria. Am J Gastroenterol. 2009 Oct;104(10):2534-42. doi: 10.1038/ajg.2009.328. Epub 2009 Jun 16. — View Citation

Jaracz J, Kucharska A, Rajewska-Rager A, Lacka K. Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma. J Endocrinol Invest. 2012 Sep;35(8):760-5. Epub 2011 Oct 6. — View Citation

Kathol RG, Delahunt JW. The relationship of anxiety and depression to symptoms of hyperthyroidism using operational criteria. Gen Hosp Psychiatry. 1986 Jan;8(1):23-8. — View Citation

Kirshner HS. Hashimoto's encephalopathy: a brief review. Curr Neurol Neurosci Rep. 2014 Sep;14(9):476. doi: 10.1007/s11910-014-0476-2. Review. — View Citation

Lee MB, Lee YJ, Yen LL, Lin MH, Lue BH. Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in clinical practice. J Formos Med Assoc. 1990 Dec;89(12):1081-7. — View Citation

Lee MB, Rin H, Lin HN, Lee YJ Personality as an effective predictor of outcome for neurotic disorders. Chinese Psychiatry 1990; 4:111-121.

Lee YC, Wang HP, Chiu HM, Liao SC, Huang SP, Lai YP, Wu MS, Chen MF, Lin JT. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol. 2006 May;21(5):798-804. — View Citation

Liao SC, Lee MB, Lee YJ, Huang TS. Hyperleptinemia in subjects with persistent partial posttraumatic stress disorder after a major earthquake. Psychosom Med. 2004 Jan-Feb;66(1):23-8. — View Citation

Liao SC, Lee MB, Lee YJ, Weng T, Shih FY, Ma MH. Association of psychological distress with psychological factors in rescue workers within two months after a major earthquake. J Formos Med Assoc. 2002 Mar;101(3):169-76. — View Citation

Schreckenberger MF, Egle UT, Drecker S, Buchholz HG, Weber MM, Bartenstein P, Kahaly GJ. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab. 2006 Dec;91(12):4786-91. Epub 2006 Sep 12. — View Citation

Smilkstein G, Ashworth C, Montano D. Validity and reliability of the family APGAR as a test of family function. J Fam Pract. 1982 Aug;15(2):303-11. — View Citation

Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves' disease. Gen Hosp Psychiatry. 1988 Jan;10(1):49-55. — View Citation

* Note: There are 18 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Psychological distress in scores measured using the Brief Symptom Rating Scale Psychological distress is measured by using the Brief Symptom Rating Scale (BSRS). The BSRS is a self-report questionnaire with 30 items rated from 0 to 4 scores on the basis of the degree of distress. BSRS covers nine dimensions of psychopathology: somatization, obsessive-compulsive disorder, interpersonal sensitivity, depression, anxiety, hostility, phobic-anxiety, paranoid ideation, and additional symptoms. Within one year after inclusion No
See also
  Status Clinical Trial Phase
Completed NCT01950260 - Early Levothyroxine Post Radioactive Iodine Phase 2/Phase 3
Completed NCT01269749 - Radioactive Iodide Therapy for Pediatric Graves' Disease Phase 2
Recruiting NCT06068179 - Graves' Disease Remission Study: MycoMeth Combo Phase 2/Phase 3
Recruiting NCT02114619 - Comparative Study of Different I-131 Doses in Graves' Disease N/A
Completed NCT04383795 - Change of Gut Microbiome in the Treatment of Graves' Disease
Completed NCT02384668 - D-vitamin And Graves' Disease; Morbidity And Relapse Reduction N/A
Completed NCT01885533 - Post-Radioiodine Graves' Management: The PRAGMA-Study N/A
Completed NCT01534169 - Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients Phase 1
Completed NCT00917241 - Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone Phase 4
Completed NCT00004660 - Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy N/A
Completed NCT02205801 - Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy N/A
Completed NCT00958113 - Autoimmune Thyroid Disease Genetic Study N/A
Completed NCT02727738 - Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole N/A
Completed NCT00697528 - Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy N/A
Completed NCT00150124 - Block-replacement Therapy During Radioiodine Therapy Phase 4
Completed NCT03535090 - Coagulation After Intravenous Methylprednisolone Administration
Not yet recruiting NCT02373995 - Role of the Microbiome in Graves' Orbitopathy Phase 1/Phase 2
Completed NCT00505011 - Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease N/A
Completed NCT02107794 - Shared Decision Making in Graves Disease - Graves Disease (GD) Choice N/A
Recruiting NCT01182584 - Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease N/A